BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kobayashi M, Farrar JL, Gierke R, Britton A, Childs L, Leidner AJ, Campos-Outcalt D, Morgan RL, Long SS, Talbot HK, Poehling KA, Pilishvili T. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:109-17. [PMID: 35085226 DOI: 10.15585/mmwr.mm7104a1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Musher DM, Anderson R, Feldman C. The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia 2022;14. [DOI: 10.1186/s41479-022-00097-y] [Reference Citation Analysis]
2 Carnalla-barajas MN, Soto-noguerón A, Martínez-medina L, Olvera-herrera ME, Mosqueda-gómez JL, Rodríguez-cortez P, Morfin-otero R, Rodriguez-noriega E, Luévanos-velázquez A, Merlo-palomera M, Esparza-ahumada S, Márquez-díaz F, Alpuche-aranda CM, Echaniz-aviles G. Diagnosis of bacterial meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae using a multiplex real-time PCR technique. Braz J Microbiol. [DOI: 10.1007/s42770-022-00826-x] [Reference Citation Analysis]
3 Takata M, Ubukata K, Miyazaki H, Iwata S, Nakamura S. Diversity of amino acid substitutions of penicillin-binding proteins in penicillin-non-susceptible and non-vaccine type Streptococcus pneumoniae. J Infect Chemother 2022:S1341-321X(22)00232-X. [PMID: 35963598 DOI: 10.1016/j.jiac.2022.08.006] [Reference Citation Analysis]
4 Maeda H, Gopal Dhoubhadel B, Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, Ishida M, Hamaguchi S, Otsuka Y, Morimoto K. Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020. Vaccine 2022:S0264-410X(22)00938-0. [PMID: 35963821 DOI: 10.1016/j.vaccine.2022.07.041] [Reference Citation Analysis]
5 Blonde L, Umpierrez GE, McGill JB, Reddy SS, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo R, Gardner TW, Garg R, Garvey WT, Hirsch IB, Hurley DL, Izuora K, Kosiborod M, Olson D, Patel S, Pop-Busui R, Sadhu AR, Samson SL, Stec C, Tamborlane WV Jr, Tuttle KR, Twining C, Vella A, Vellanki P, Weber SL. WITHDRAWN: American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocr Pract 2022:S1530-891X(22)00576-6. [PMID: 35963508 DOI: 10.1016/j.eprac.2022.08.002] [Reference Citation Analysis]
6 Richardson NI, Kuttel MM, Ravenscroft N. Modeling of pneumococcal serogroup 10 capsular polysaccharide molecular conformations provides insight into epitopes and observed cross-reactivity. Front Mol Biosci 2022;9:961532. [DOI: 10.3389/fmolb.2022.961532] [Reference Citation Analysis]
7 Narsingam S, Munson J, Drescher F. Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.07.035] [Reference Citation Analysis]
8 Nasreen S, Gebretekle GB, Lynch M, Kurdina A, Thomas M, Fadel S, Houle SKD, Waite NM, Crowcroft NS, Allin S. Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review. Vaccine 2022;40:4380-93. [PMID: 35781171 DOI: 10.1016/j.vaccine.2022.06.056] [Reference Citation Analysis]
9 Waterer G. Vaccination in patients with COPD : COVID has raised the bar. Respirology. [DOI: 10.1111/resp.14331] [Reference Citation Analysis]
10 Smith KJ, Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK. Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA. Infect Dis Ther 2022. [PMID: 35831685 DOI: 10.1007/s40121-022-00669-x] [Reference Citation Analysis]
11 Crosby S, Schuh MJ, Becker M, Ivanov M, Caldera F, Farraye FA. New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac150. [PMID: 35830419 DOI: 10.1093/ibd/izac150] [Reference Citation Analysis]
12 Shirley M. 20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults. Drugs. [DOI: 10.1007/s40265-022-01733-z] [Reference Citation Analysis]
13 Xu F, deJong N, Kappelman MD, Greenlund KJ, Carlson SA. Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac129. [PMID: 35779060 DOI: 10.1093/ibd/izac129] [Reference Citation Analysis]
14 Abouqal R, Beji M, Chakroun M, Marhoum El Filali K, Rammaoui J, Zaghden H. Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco. Front Public Health 2022;10:903376. [DOI: 10.3389/fpubh.2022.903376] [Reference Citation Analysis]
15 Huang L, Wasserman M, Grant L, Farkouh R, Snow V, Arguedas A, Chilson E, Sato R, Perdrizet J. Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States. Vaccine 2022:S0264-410X(22)00773-3. [PMID: 35753839 DOI: 10.1016/j.vaccine.2022.06.024] [Reference Citation Analysis]
16 Ulanova M, Huska B, Dubois S, McCready W. Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine. Vaccine 2022:S0264-410X(22)00810-6. [PMID: 35738971 DOI: 10.1016/j.vaccine.2022.06.042] [Reference Citation Analysis]
17 Liapikou A, Konstantinidis A, Kossyvaki V, Skiadas J, Menegas D, Méndez C, Beavon R, Begier E, Gessner BD, Milionis H, Tsimihodimos V, Baxevanos G, Argiriadou T, Terrovitou C, Toumbis M, Study Group TE, Moses E, Angelos L, Ilias T, Aikaterini P, Valentina S, Iro R, Konstantinos E, Konstantina G, Christos K, Elias L, Thomas T, Georgios D, Evaggelia C, Nikolaos Z, Lampros P, Vasilios I, Elisavet F, Daniil D, Ioanna K, Anastasia C, Eleni T; EGNATIA Study Group. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019. Hum Vaccin Immunother 2022;:2079923. [PMID: 35703733 DOI: 10.1080/21645515.2022.2079923] [Reference Citation Analysis]
18 Ljunghill Hedberg A, Pauksens K, Enblad P, Larsson A, Sjölin J. Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved? Hum Vaccin Immunother 2022;:2088971. [PMID: 35704795 DOI: 10.1080/21645515.2022.2088971] [Reference Citation Analysis]
19 Thomson D, Stang A, Owoyemi I. Chronic kidney disease and vaccinations-A practical guide for primary care providers. J Natl Med Assoc 2022;114:S20-4. [PMID: 35654631 DOI: 10.1016/j.jnma.2022.05.003] [Reference Citation Analysis]
20 O’neill JH. Pneumococcal Immunization for Adults in 2022. Delaware Journal of Public Health 2022;8:36-8. [DOI: 10.32481/djph.2022.03.006] [Reference Citation Analysis]
21 Murthy N, Wodi AP, Bernstein H, McNally V, Cineas S, Ault K. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:229-33. [PMID: 35176010 DOI: 10.15585/mmwr.mm7107a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]